Cancer cachexia: Mediators, signaling, and metabolic pathways

Cell Metabolism

Volumn 16, Issue 2, 2012, Pages 153-166

  Fearon, Kenneth C H ^a   Glass, David J ^b   Guttridge, Denis C ^c  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 2; ACTIVIN; ACTIVIN A; ATROGIN 1; GLUCOSE TRANSPORTER 4; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 6; JANUS KINASE; MESSENGER RNA; MUSCLE RING FINGER 1 PROTEIN; MYOGENIN; MYOSTATIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1BETA; PROTEIN C JUN; PROTEIN KINASE B; SELECTIVE ANDROGEN RECEPTOR MODULATOR; SMAD2 PROTEIN; SMAD3 PROTEIN; STAT PROTEIN; SYNAPTOPHYSIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA2; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; UBIQUITIN PROTEIN LIGASE E3; UNINDEXED DRUG;

ADIPOSE TISSUE; CACHEXIA; CLINICAL FEATURE; CYTOKINE PRODUCTION; DIGESTIVE SYSTEM CANCER; DISEASE ASSOCIATION; DRUG TOLERANCE; ENERGY EXPENDITURE; FOOD INTAKE; HUMAN; HYPERMETABOLISM; IMMUNE SYSTEM; LIPOLYSIS; MUSCLE ATROPHY; MUSCLE HYPERTROPHY; NONHUMAN; OBESITY; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SKELETAL MUSCLE; WEIGHT REDUCTION;

ACTIVINS; CACHEXIA; HUMANS; INTERLEUKIN-6; LIPOLYSIS; METABOLIC NETWORKS AND PATHWAYS; MODELS, BIOLOGICAL; MUSCULAR ATROPHY; MYOSTATIN; NEOPLASMS; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84864646651     PISSN: 15504131     EISSN: 19327420     Source Type: Journal    
DOI: 10.1016/j.cmet.2012.06.011     Document Type: Review

References (183)

1. S. Acharyya, M.E. Butchbach, Z. Sahenk, H. Wang, M. Saji, M. Carathers, M.D. Ringel, R.J. Skipworth, K.C. Fearon, and M.A. Hollingsworth Dystrophin glycoprotein complex dysfunction: a regulatory link between muscular dystrophy and cancer cachexia Cancer Cell 8 2005 421 432 (Pubitemid 41579836)
2. T. Agustsson, M.A. D'souza, G. Nowak, and B. Isaksson Mechanisms for skeletal muscle insulin resistance in patients with pancreatic ductal adenocarcinoma Nutrition 27 2011 796 801
3. B. Ahmed, J.A. Tschen, P.R. Cohen, M.H. Zaki, P.L. Rady, S.K. Tyring, R.E. Corringham, and R. Kurzrock Cutaneous castleman's disease responds to anti interleukin-6 treatment Mol. Cancer Ther. 6 2007 2386 2390 (Pubitemid 47480403)
4. Y. Aoki, R. Yarchoan, K. Wyvill, S. Okamoto, R.F. Little, and G. Tosato Detection of viral interleukin-6 in Kaposi sarcoma-associated herpesvirus-linked disorders Blood 97 2001 2173 2176 (Pubitemid 32239103)
5. Z. Arany, B.K. Wagner, Y. Ma, J. Chinsomboon, D. Laznik, and B.M. Spiegelman Gene expression-based screening identifies microtubule inhibitors as inducers of PGC-1alpha and oxidative phosphorylation Proc. Natl. Acad. Sci. USA 105 2008 4721 4726 (Pubitemid 351753813)
6. M.L. Asp, M. Tian, A.A. Wendel, and M.A. Belury Evidence for the contribution of insulin resistance to the development of cachexia in tumor-bearing mice Int. J. Cancer 126 2010 756 763
7. D. Attaix, and V.E. Baracos MAFbx/Atrogin-1 expression is a poor index of muscle proteolysis Curr. Opin. Clin. Nutr. Metab. Care 13 2010 223 224
8. Z. Aversa, A. Bonetto, F. Penna, P. Costelli, G. Di Rienzo, A. Lacitignola, F.M. Baccino, V. Ziparo, P. Mercantini, F.R. Fanelli, and M. Muscaritoli Changes in myostatin signaling in non-weight-losing cancer patients Ann. Surg. Oncol. 19 2012 1350 1356
9. K. Baar, A.R. Wende, T.E. Jones, M. Marison, L.A. Nolte, M. Chen, D.P. Kelly, and J.O. Holloszy Adaptations of skeletal muscle to exercise: rapid increase in the transcriptional coactivator PGC-1 FASEB J. 16 2002 1879 1886 (Pubitemid 35462607)
10. C. Badorff, H. Ruetten, S. Mueller, M. Stahmer, D. Gehring, F. Jung, C. Ihling, A.M. Zeiher, and S. Dimmeler Fas receptor signaling inhibits glycogen synthase kinase 3 beta and induces cardiac hypertrophy following pressure overload J. Clin. Invest. 109 2002 373 381 (Pubitemid 34141811)
11. K.A. Baltgalvis, F.G. Berger, M.M. Pena, J.M. Davis, S.J. Muga, and J.A. Carson Interleukin-6 and cachexia in ApcMin/+ mice Am. J. Physiol. Regul. Integr. Comp. Physiol. 294 2008 R393 R401
12. V.E. Baracos, T. Reiman, M. Mourtzakis, I. Gioulbasanis, and S. Antoun Body composition in patients with non-small cell lung cancer: a contemporary view of cancer cachexia with the use of computed tomography image analysis Am. J. Clin. Nutr. 91 2010 1133S 1137S
13. T.J. Bayliss, J.T. Smith, M. Schuster, K.H. Dragnev, and J.R. Rigas A humanized anti-IL-6 antibody (ALD518) in non-small cell lung cancer Expert Opin. Biol. Ther. 11 2011 1663 1668
14. S.A. Beck, and M.J. Tisdale Effect of cancer cachexia on triacylglycerol/fatty acid substrate cycling in white adipose tissue Lipids 39 2004 1187 1189
15. N. Bennani-Baiti, and D. Walsh Animal models of the cancer anorexia-cachexia syndrome Support. Care Cancer 19 2011 1451 1463
16. M.E. Benny Klimek, T. Aydogdu, M.J. Link, M. Pons, L.G. Koniaris, and T.A. Zimmers Acute inhibition of myostatin-family proteins preserves skeletal muscle in mouse models of cancer cachexia Biochem. Biophys. Res. Commun. 391 2010 1548 1554
17. C.F. Bentzinger, K. Romanino, D. Cloëtta, S. Lin, J.B. Mascarenhas, F. Oliveri, J. Xia, E. Casanova, C.F. Costa, and M. Brink Skeletal muscle-specific ablation of raptor, but not of rictor, causes metabolic changes and results in muscle dystrophy Cell Metab. 8 2008 411 424
18. B. Beutler, and A. Cerami Cachectin and tumour necrosis factor as two sides of the same biological coin Nature 320 1986 584 588 (Pubitemid 16039134)
19. C. Bing, Y. Bao, J. Jenkins, P. Sanders, M. Manieri, S. Cinti, M.J. Tisdale, and P. Trayhurn Zinc-alpha2-glycoprotein, a lipid mobilizing factor, is expressed in adipocytes and is up-regulated in mice with cancer cachexia Proc. Natl. Acad. Sci. USA 101 2004 2500 2505 (Pubitemid 38269340)
20. K. Black, I.R. Garrett, and G.R. Mundy Chinese hamster ovarian cells transfected with the murine interleukin-6 gene cause hypercalcemia as well as cachexia, leukocytosis and thrombocytosis in tumor-bearing nude mice Endocrinology 128 1991 2657 2659
21. P.W. Bodell, E. Kodesh, F. Haddad, F.P. Zaldivar, D.M. Cooper, and G.R. Adams Skeletal muscle growth in young rats is inhibited by chronic exposure to IL-6 but preserved by concurrent voluntary endurance exercise J. Appl. Physiol. 106 2009 443 453
22. S.C. Bodine, E. Latres, S. Baumhueter, V.K. Lai, L. Nunez, B.A. Clarke, W.T. Poueymirou, F.J. Panaro, E. Na, and K. Dharmarajan Identification of ubiquitin ligases required for skeletal muscle atrophy Science 294 2001 1704 1708 (Pubitemid 33104839)
23. S.C. Bodine, T.N. Stitt, M. Gonzalez, W.O. Kline, G.L. Stover, R. Bauerlein, E. Zlotchenko, A. Scrimgeour, J.C. Lawrence, D.J. Glass, and G.D. Yancopoulos Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo Nat. Cell Biol. 3 2001 1014 1019 (Pubitemid 34428747)
24. S. Bogdanovich, T.O. Krag, E.R. Barton, L.D. Morris, L.A. Whittemore, R.S. Ahima, and T.S. Khurana Functional improvement of dystrophic muscle by myostatin blockade Nature 420 2002 418 421 (Pubitemid 35415652)
25. A. Bonetto, T. Aydogdu, N. Kunzevitzky, D.C. Guttridge, S. Khuri, L.G. Koniaris, and T.A. Zimmers STAT3 activation in skeletal muscle links muscle wasting and the acute phase response in cancer cachexia PLoS ONE 6 2011 e22538
26. K.L. Borden, and P.S. Freemont The RING finger domain: a recent example of a sequence-structure family Curr. Opin. Struct. Biol. 6 1996 395 401
27. I. Bosaeus, P. Daneryd, E. Svanberg, and K. Lundholm Dietary intake and resting energy expenditure in relation to weight loss in unselected cancer patients Int. J. Cancer 93 2001 380 383 (Pubitemid 32592057)
28. M. Bossola, M. Muscaritoli, P. Costelli, G. Grieco, G. Bonelli, F. Pacelli, F. Rossi Fanelli, G.B. Doglietto, and F.M. Baccino Increased muscle proteasome activity correlates with disease severity in gastric cancer patients Ann. Surg. 237 2003 384 389 (Pubitemid 38176454)
29. D. Cai, J.D. Frantz, N.E. Tawa Jr., P.A. Melendez, B.C. Oh, H.G. Lidov, P.O. Hasselgren, W.R. Frontera, J. Lee, D.J. Glass, and S.E. Shoelson IKKbeta/NF-kappaB activation causes severe muscle wasting in mice Cell 119 2004 285 298 (Pubitemid 39360909)
30. J.M. Carrascosa, P. Martínez, and I. Núñez de Castro Nitrogen movement between host and tumor in mice inoculated with Ehrlich ascitic tumor cells Cancer Res. 44 1984 3831 3835 (Pubitemid 14041599)
31. J.V. Castell, M.J. Gómez-Lechón, M. David, T. Andus, T. Geiger, R. Trullenque, R. Fabra, and P.C. Heinrich Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes FEBS Lett. 242 1989 237 239 (Pubitemid 19020112)
32. A. Chauhan, A. Sequeria, C. Manderson, M. Maddocks, D. Wasley, and A. Wilcock Exploring autonomic nervous system dysfunction in patients with cancer cachexia: a pilot study Auton. Neurosci. 166 2012 93 95
33. S.Z. Chen, and Z.G. Qiu Combined treatment with GH, insulin, and indomethacin alleviates cancer cachexia in a mouse model J. Endocrinol. 208 2011 131 136
34. B.A. Clarke, D. Drujan, M.S. Willis, L.O. Murphy, R.A. Corpina, E. Burova, S.V. Rakhilin, T.N. Stitt, C. Patterson, E. Latres, and D.J. Glass The E3 Ligase MuRF1 degrades myosin heavy chain protein in dexamethasone-treated skeletal muscle Cell Metab. 6 2007 376 385 (Pubitemid 350011998)
35. S. Cohen, J.J. Brault, S.P. Gygi, D.J. Glass, D.M. Valenzuela, C. Gartner, E. Latres, and A.L. Goldberg During muscle atrophy, thick, but not thin, filament components are degraded by MuRF1-dependent ubiquitylation J. Cell Biol. 185 2009 1083 1095
36. S.H. Cohn, W. Gartenhaus, A. Sawitsky, K. Rai, I. Zanzi, A. Vaswani, K.J. Ellis, S. Yasumura, E. Cortes, and D. Vartsky Compartmental body composition of cancer patients by measurement of total body nitrogen, potassium, and water Metabolism 30 1981 222 229 (Pubitemid 11159747)
37. P. Collins, C. Bing, P. McCulloch, and G. Williams Muscle UCP-3 mRNA levels are elevated in weight loss associated with gastrointestinal adenocarcinoma in humans Br. J. Cancer 86 2002 372 375 (Pubitemid 34185120)
38. A. Csibi, M.-P. Leibovitch, K. Cornille, L.A. Tintignac, and S.A. Leibovitch MAFbx/Atrogin-1 controls the activity of the initiation factor eIF3-f in skeletal muscle atrophy by targeting multiple C-terminal lysines J. Biol. Chem. 284 2009 4413 4421
39. D. Cuthbertson, K. Smith, J. Babraj, G. Leese, T. Waddell, P. Atherton, H. Wackerhage, P.M. Taylor, and M.J. Rennie Anabolic signaling deficits underlie amino acid resistance of wasting, aging muscle FASEB J. 19 2005 422 424 (Pubitemid 40316537)
40. I. Dahlman, N. Mejhert, K. Linder, T. Agustsson, D.M. Mutch, A. Kulyte, B. Isaksson, J. Permert, N. Petrovic, and J. Nedergaard Adipose tissue pathways involved in weight loss of cancer cachexia Br. J. Cancer 102 2010 1541 1548
41. C.V. Dang PKM2 tyrosine phosphorylation and glutamine metabolism signal a different view of the Warburg effect Sci. Signal. 2 2009 pe75
42. S.K. Das, S. Eder, S. Schauer, C. Diwoky, H. Temmel, B. Guertl, G. Gorkiewicz, K.P. Tamilarasan, P. Kumari, and M. Trauner Adipose triglyceride lipase contributes to cancer-associated cachexia Science 333 2011 233 238
43. D.A. Deans, B.H. Tan, J.A. Ross, M. Rose-Zerilli, S.J. Wigmore, W.M. Howell, R.F. Grimble, and K.C. Fearon Cancer cachexia is associated with the IL10 -1082 gene promoter polymorphism in patients with gastroesophageal malignancy Am. J. Clin. Nutr. 89 2009 1164 1172
44. C.H. DeJong, S. Busquets, A.G. Moses, P. Schrauwen, J.A. Ross, J.M. Argiles, and K.C. Fearon Systemic inflammation correlates with increased expression of skeletal muscle ubiquitin but not uncoupling proteins in cancer cachexia Oncol. Rep. 14 2005 257 263
45. E. Del Fabbro, D. Hui, S. Dalal, R. Dev, Z.I. Nooruddin, and E. Bruera Clinical outcomes and contributors to weight loss in a cancer cachexia clinic J. Palliat. Med. 14 2011 1004 1008
46. R. Dev, D. Hui, S. Dalal, Z.I. Nooruddin, S. Yennurajalingam, E. Del Fabbro, and E. Bruera Association between serum cortisol and testosterone levels, opioid therapy, and symptom distress in patients with advanced cancer J. Pain Symptom Manage. 41 2011 788 795
47. W.D. Dewys, C. Begg, P.T. Lavin, P.R. Band, J.M. Bennett, J.R. Bertino, M.H. Cohen, H.O. Douglass Jr., P.F. Engstrom, E.Z. Ezdinli Eastern Cooperative Oncology Group Prognostic effect of weight loss prior to chemotherapy in cancer patients Am. J. Med. 69 1980 491 497 (Pubitemid 10018703)
48. C. Dogra, H. Changotra, N. Wedhas, X. Qin, J.E. Wergedal, and A. Kumar TNF-related weak inducer of apoptosis (TWEAK) is a potent skeletal muscle-wasting cytokine FASEB J. 21 2007 1857 1869 (Pubitemid 46855631)
49. C. Drott, G. Svaninger, and K. Lundholm Increased urinary excretion of cortisol and catecholami-NES in malnourished cancer patients Ann. Surg. 208 1988 645 650 (Pubitemid 18267709)
50. E. Edén, S. Edström, K. Bennegård, T. Scherstén, and K. Lundholm Glucose flux in relation to energy expenditure in malnourished patients with and without cancer during periods of fasting and feeding Cancer Res. 44 1984 1718 1724
51. P.W. Emery, R.H. Edwards, M.J. Rennie, R.L. Souhami, and D. Halliday Protein synthesis in muscle measured in vivo in cachectic patients with cancer Br. Med. J. (Clin. Res. Ed.) 289 1984 584 586 (Pubitemid 14009869)
52. J.S. Falconer, K.C.H. Fearon, C.E. Plester, J.A. Ross, and D.C. Carter Cytokines, the acute-phase response, and resting energy expenditure in cachectic patients with pancreatic cancer Ann. Surg. 219 1994 325 331 (Pubitemid 24121444)
53. K.C. Fearon Cancer cachexia: developing multimodal therapy for a multidimensional problem Eur. J. Cancer 44 2008 1124 1132
54. K.C. Fearon, and T. Preston Body composition in cancer cachexia Infusionstherapie 17 Suppl 3 1990 63 66 (Pubitemid 20199173)
55. K.C. Fearon, J.S. Falconer, C. Slater, D.C. McMillan, J.A. Ross, and T. Preston Albumin synthesis rates are not decreased in hypoalbuminemic cachectic cancer patients with an ongoing acute-phase protein response Ann. Surg. 227 1998 249 254 (Pubitemid 28087919)
56. K. Fearon, F. Strasser, S.D. Anker, I. Bosaeus, E. Bruera, R.L. Fainsinger, A. Jatoi, C. Loprinzi, N. MacDonald, and G. Mantovani Definition and classification of cancer cachexia: an international consensus Lancet Oncol. 12 2011 489 495
57. M. Fouladiun, U. Körner, I. Bosaeus, P. Daneryd, A. Hyltander, and K.G. Lundholm Body composition and time course changes in regional distribution of fat and lean tissue in unselected cancer patients on palliative care - correlations with food intake, metabolism, exercise capacity, and hormones Cancer 103 2005 2189 2198 (Pubitemid 40605128)
58. R.A. Frost, G.J. Nystrom, L.S. Jefferson, and C.H. Lang Hormone, cytokine, and nutritional regulation of sepsis-induced increases in atrogin-1 and MuRF1 in skeletal muscle Am. J. Physiol. Endocrinol. Metab. 292 2007 E501 E512
59. I.J. Gallagher, N.A. Stephens, A.J. Macdonald, R.J.E. Skipworth, H. Husi, C.A. Greig, J.A. Ross, J.A. Timmons, and K.C.H. Fearon Suppression of skeletal muscle turnover in cancer cachexia: evidence from the transcriptome in sequential human muscle biopsies Clin. Cancer Res. 18 2012 2817 2827
60. D.J. Glass Signaling pathways perturbing muscle mass Curr. Opin. Clin. Nutr. Metab. Care 13 2010 225 229
61. A. Goel, S.P. Mathupala, and P.L. Pedersen Glucose metabolism in cancer. Evidence that demethylation events play a role in activating type II hexokinase gene expression J. Biol. Chem. 278 2003 15333 15340 (Pubitemid 36799872)
62. E. Gold, and G. Risbridger Activins and activin antagonists in the prostate and prostate cancer Mol. Cell. Endocrinol. 359 2012 107 112
63. M.D. Gomes, S.H. Lecker, R.T. Jagoe, A. Navon, and A.L. Goldberg Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy Proc. Natl. Acad. Sci. USA 98 2001 14440 14445 (Pubitemid 33121410)
64. A.J. Grossberg, J.M. Scarlett, and D.L. Marks Hypothalamic mechanisms in cachexia Physiol. Behav. 100 2010 478 489
65. D.C. Guttridge, M.W. Mayo, L.V. Madrid, C.Y. Wang, and A.S. Baldwin Jr. NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia Science 289 2000 2363 2366
66. C. Handschin, Y.M. Kobayashi, S. Chin, P. Seale, K.P. Campbell, and B.M. Spiegelman PGC-1alpha regulates the neuromuscular junction program and ameliorates Duchenne muscular dystrophy Genes Dev. 21 2007 770 783 (Pubitemid 46572357)
67. M.P. Hedger, W.R. Winnall, D.J. Phillips, and D.M. de Kretser The regulation and functions of activin and follistatin in inflammation and immunity Vitam. Horm. 85 2011 255 297
68. S.B. Heymsfield, and C.B. McManus Tissue components of weight loss in cancer patients. A new method of study and preliminary observations Cancer 55 1, Suppl 1985 238 249 (Pubitemid 15155448)
69. C.P. Holroyde, T.G. Gabuzda, R.C. Putnam, P. Paul, and G.A. Reichard Altered glucose metabolism in metastatic carcinoma Cancer Res. 35 1975 3710 3714
70. C.P. Holroyde, R.S. Axelrod, C.L. Skutches, A.C. Haff, P. Paul, and G.A. Reichard Lactate metabolism in patients with metastatic colorectal cancer Cancer Res. 39 1979 4900 4904 (Pubitemid 10167717)
71. G.S. Hotamisligil Mechanisms of TNF-alpha-induced insulin resistance Exp. Clin. Endocrinol. Diabetes 107 1999 119 125
72. S. Hu, A. Balakrishnan, R.A. Bok, B. Anderton, P.E. Larson, S.J. Nelson, J. Kurhanewicz, D.B. Vigneron, and A. Goga 13C-pyruvate imaging reveals alterations in glycolysis that precede c-Myc-induced tumor formation and regression Cell Metab. 14 2011 131 142
73. A. Hyltander, C. Drott, U. Körner, R. Sandström, and K. Lundholm Elevated energy expenditure in cancer patients with solid tumours Eur. J. Cancer 27 1991 9 15
74. C. Ibebunjo, J.K. Eash, C. Li, Q. Ma, and D.J. Glass Voluntary running, skeletal muscle gene expression, and signaling inversely regulated by orchidectomy and testosterone replacement Am. J. Physiol. Endocrinol. Metab. 300 2011 E327 E340
75. H. Inadera, S. Nagai, H.Y. Dong, and K. Matsushima Molecular analysis of lipid-depleting factor in a colon-26-inoculated cancer cachexia model Int. J. Cancer 101 2002 37 45 (Pubitemid 34832995)
76. Y. Izumiya, T. Hopkins, C. Morris, K. Sato, L. Zeng, J. Viereck, J.A. Hamilton, N. Ouchi, N.K. LeBrasseur, and K. Walsh Fast/Glycolytic muscle fiber growth reduces fat mass and improves metabolic parameters in obese mice Cell Metab. 7 2008 159 172 (Pubitemid 351168553)
77. R.T. Jagoe, C.P.F. Redfern, R.G. Roberts, G.J. Gibson, and T.H.J. Goodship Skeletal muscle mRNA levels for cathepsin B, but not components of the ubiquitin-proteasome pathway, are increased in patients with lung cancer referred for thoracotomy Clin. Sci. 102 2002 353 361 (Pubitemid 34214399)
78. A. Jatoi, H.L. Ritter, A. Dueck, P.L. Nguyen, D.A. Nikcevich, R.F. Luyun, B.I. Mattar, and C.L. Loprinzi A placebo-controlled, double-blind trial of infliximab for cancer-associated weight loss in elderly and/or poor performance non-small cell lung cancer patients (N01C9) Lung Cancer 68 2010 234 239
79. A.P. John Dysfunctional mitochondria, not oxygen insufficiency, cause cancer cells to produce inordinate amounts of lactic acid: the impact of this on the treatment of cancer Med. Hypotheses 57 2001 429 431 (Pubitemid 33052031)
80. Y. Kamei, S. Miura, M. Suzuki, Y. Kai, J. Mizukami, T. Taniguchi, K. Mochida, T. Hata, J. Matsuda, and H. Aburatani Skeletal muscle FOXO1 (FKHR) transgenic mice have less skeletal muscle mass, down-regulated Type I (slow twitch/red muscle) fiber genes, and impaired glycemic control J. Biol. Chem. 279 2004 41114 41123 (Pubitemid 39287713)
81. J. Khal, A.V. Hine, K.C.H. Fearon, C.H.C. Dejong, and M.J. Tisdale Increased expression of proteasome subunits in skeletal muscle of cancer patients with weight loss Int. J. Biochem. Cell Biol. 37 2005 2196 2206 (Pubitemid 41206831)
82. E.L. Kovacheva, A.P. Hikim, R. Shen, I. Sinha, and I. Sinha-Hikim Testosterone supplementation reverses sarcopenia in aging through regulation of myostatin, c-Jun NH2-terminal kinase, Notch, and Akt signaling pathways Endocrinology 151 2010 628 638
83. B.J. Krawiec, R.A. Frost, T.C. Vary, L.S. Jefferson, and C.H. Lang Hindlimb casting decreases muscle mass in part by proteasome-dependent proteolysis but independent of protein synthesis Am. J. Physiol. Endocrinol. Metab. 289 2005 E969 E980
84. J. Lagirand-Cantaloube, N. Offner, A. Csibi, M.P. Leibovitch, S. Batonnet-Pichon, L.A. Tintignac, C.T. Segura, and S.A. Leibovitch The initiation factor eIF3-f is a major target for atrogin1/MAFbx function in skeletal muscle atrophy EMBO J. 27 2008 1266 1276 (Pubitemid 351574748)
85. K.M.V. Lai, M. Gonzalez, W.T. Poueymirou, W.O. Kline, E. Na, E. Zlotchenko, T.N. Stitt, A.N. Economides, G.D. Yancopoulos, and D.J. Glass Conditional activation of akt in adult skeletal muscle induces rapid hypertrophy Mol. Cell. Biol. 24 2004 9295 9304 (Pubitemid 39391668)
86. A. Laviano, A. Inui, D.L. Marks, M.M. Meguid, C. Pichard, F. Rossi Fanelli, and M. Seelaender Neural control of the anorexia-cachexia syndrome Am. J. Physiol. Endocrinol. Metab. 295 2008 E1000 E1008
87. S.H. Lecker, R.T. Jagoe, A. Gilbert, M. Gomes, V. Baracos, J. Bailey, S.R. Price, W.E. Mitch, and A.L. Goldberg Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression FASEB J. 18 2004 39 51 (Pubitemid 38076464)
88. S.J. Lee, L.A. Reed, M.V. Davies, S. Girgenrath, M.E. Goad, K.N. Tomkinson, J.F. Wright, C. Barker, G. Ehrmantraut, and J. Holmstrom Regulation of muscle growth by multiple ligands signaling through activin type II receptors Proc. Natl. Acad. Sci. USA 102 2005 18117 18122 (Pubitemid 41798511)
89. G. Leto, L. Incorvaia, G. Badalamenti, F.M. Tumminello, N. Gebbia, C. Flandina, M. Crescimanno, and G. Rini Activin A circulating levels in patients with bone metastasis from breast or prostate cancer Clin. Exp. Metastasis 23 2006 117 122 (Pubitemid 44440171)
90. Y.P. Li, Y. Chen, J. John, J. Moylan, B. Jin, D.L. Mann, and M.B. Reid TNF-alpha acts via p38 MAPK to stimulate expression of the ubiquitin ligase atrogin1/MAFbx in skeletal muscle FASEB J. 19 2005 362 370 (Pubitemid 40316524)
91. L. Li, J.J. Shen, J.C. Bournat, L. Huang, A. Chattopadhyay, Z. Li, C. Shaw, B.H. Graham, and C.W. Brown Activin signaling: effects on body composition and mitochondrial energy metabolism Endocrinology 150 2009 3521 3529
92. J.R. Lieffers, M. Mourtzakis, K.D. Hall, L.J. McCargar, C.M.M. Prado, and V.E. Baracos A viscerally driven cachexia syndrome in patients with advanced colorectal cancer: contributions of organ and tumor mass to whole-body energy demands Am. J. Clin. Nutr. 89 2009 1173 1179
93. J. Lin, H. Wu, P.T. Tarr, C.Y. Zhang, Z. Wu, O. Boss, L.F. Michael, P. Puigserver, E. Isotani, and E.N. Olson Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres Nature 418 2002 797 801
94. M. Llovera, C. García-Martínez, J. López-Soriano, N. Carbó, N. Agell, F.J. López-Soriano, and J.M. Argiles Role of TNF receptor 1 in protein turnover during cancer cachexia using gene knockout mice Mol. Cell. Endocrinol. 142 1998 183 189 (Pubitemid 28438290)
95. S. Lokireddy, V. Mouly, G. Butler-Browne, P.D. Gluckman, M. Sharma, R. Kambadur, and C. McFarlane Myostatin promotes the wasting of human myoblast cultures through promoting ubiquitin-proteasome pathway-mediated loss of sarcomeric proteins Am. J. Physiol. Cell Physiol. 301 2011 C1316 C1324
96. J.J. Lum, R.J. DeBerardinis, and C.B. Thompson Autophagy in metazoans: cell survival in the land of plenty Nat. Rev. Mol. Cell Biol. 6 2005 439 448 (Pubitemid 40780556)
97. K. Lundholm, S. Edström, I. Karlberg, L. Ekman, and T. Scherstén Glucose turnover, gluconeogenesis from glycerol, and estimation of net glucose cycling in cancer patients Cancer 50 1982 1142 1150 (Pubitemid 12062893)
98. K. Lundholm, U. Körner, L. Gunnebo, P. Sixt-Ammilon, M. Fouladiun, P. Daneryd, and I. Bosaeus Insulin treatment in cancer cachexia: effects on survival, metabolism, and physical functioning Clin. Cancer Res. 13 2007 2699 2706 (Pubitemid 46788038)
99. M. Maltoni, L. Fabbri, O. Nanni, E. Scarpi, L. Pezzi, E. Flamini, A. Riccobon, S. Derni, G. Pallotti, and D. Amadori Serum levels of tumour necrosis factor alpha and other cytokines do not correlate with weight loss and anorexia in cancer patients Support. Care Cancer 5 1997 130 135 (Pubitemid 27163454)
100. C. Mammucari, G. Milan, V. Romanello, E. Masiero, R. Rudolf, P. Del Piccolo, S.J. Burden, R. Di Lisi, C. Sandri, and J. Zhao FoxO3 controls autophagy in skeletal muscle in vivo Cell Metab. 6 2007 458 471 (Pubitemid 350163055)
101. M.E. Martignoni, P. Kunze, W. Hildebrandt, B. Künzli, P. Berberat, T. Giese, O. Klöters, J. Hammer, M.W. Büchler, N.A. Giese, and H. Friess Role of mononuclear cells and inflammatory cytokines in pancreatic cancer-related cachexia Clin. Cancer Res. 11 2005 5802 5808 (Pubitemid 41170306)
102. A. Matsakas, R. Macharia, A. Otto, M.I. Elashry, E. Mouisel, V. Romanello, R. Sartori, H. Amthor, M. Sandri, V. Narkar, and K. Patel Exercise training attenuates the hypermuscular phenotype and restores skeletal muscle function in the myostatin null mouse Exp. Physiol. 97 2012 125 140
103. J.L. McCall, J.A. Tuckey, and B.R. Parry Serum tumour necrosis factor alpha and insulin resistance in gastrointestinal cancer Br. J. Surg. 79 1992 1361 1363 (Pubitemid 23008406)
104. S.L. McGee, K.J. Mustard, D.G. Hardie, and K. Baar Normal hypertrophy accompanied by phosphoryation and activation of AMP-activated protein kinase alpha1 following overload in LKB1 knockout mice J. Physiol. 586 2008 1731 1741 (Pubitemid 351404971)
105. M.J. Menconi, Z.P. Arany, N. Alamdari, Z. Aversa, P. Gonnella, P. O'Neal, I.J. Smith, S. Tizio, and P.-O. Hasselgren Sepsis and glucocorticoids downregulate the expression of the nuclear cofactor PGC-1β in skeletal muscle Am. J. Physiol. Endocrinol. Metab. 299 2010 E533 E543
106. J.R. Mendell, and W.K. Engel The fine structure of type II muscle fiber atrophy Neurology 21 1971 358 365
107. V. Mieulet, M. Roceri, C. Espeillac, A. Sotiropoulos, M. Ohanna, V. Oorschot, J. Klumperman, M. Sandri, and M. Pende S6 kinase inactivation impairs growth and translational target phosphorylation in muscle cells maintaining proper regulation of protein turnover Am. J. Physiol. Cell Physiol. 293 2007 C712 C722
108. A. Mittal, S. Bhatnagar, A. Kumar, E. Lach-Trifilieff, S. Wauters, H. Li, D.Y. Makonchuk, D.J. Glass, and A. Kumar The TWEAK-Fn14 system is a critical regulator of denervation-induced skeletal muscle atrophy in mice J. Cell Biol. 188 2010 833 849
109. C.L. Monitto, D. Berkowitz, K.M. Lee, S. Pin, D. Li, M. Breslow, B. O'Malley, and M. Schiller Differential gene expression in a murine model of cancer cachexia Am. J. Physiol. Endocrinol. Metab. 281 2001 E289 E297
110. R. Moore-Carrasco, S. Busquets, V. Almendro, M. Palanki, F.J. López-Soriano, and J.M. Argilés The AP-1/NF-kappaB double inhibitor SP100030 can revert muscle wasting during experimental cancer cachexia Int. J. Oncol. 30 2007 1239 1245
111. C. Morisco, K. Seta, S.E. Hardt, Y. Lee, S.F. Vatner, and J. Sadoshima Glycogen synthase kinase 3beta regulates GATA4 in cardiac myocytes J. Biol. Chem. 276 2001 28586 28597
112. A.G. Moses, J. Maingay, K. Sangster, K.C. Fearon, and J.A. Ross Pro-inflammatory cytokine release by peripheral blood mononuclear cells from patients with advanced pancreatic cancer: relationship to acute phase response and survival Oncol. Rep. 21 2009 1091 1095
113. D.S. Mosher, P. Quignon, C.D. Bustamante, N.B. Sutter, C.S. Mellersh, H.G. Parker, and E.A. Ostrander A mutation in the myostatin gene increases muscle mass and enhances racing performance in heterozygote dogs PLoS Genet. 3 2007 e79
114. J.S. Moylan, J.D. Smith, M.A. Chambers, T.J. McLoughlin, and M.B. Reid TNF induction of atrogin-1/MAFbx mRNA depends on Foxo4 expression but not AKT-Foxo1/3 signaling Am. J. Physiol. Cell Physiol. 295 2008 C986 C993
115. T. Mracek, N.A. Stephens, D. Gao, Y. Bao, J.A. Ross, M. Rydén, P. Arner, P. Trayhurn, K.C. Fearon, and C. Bing Enhanced ZAG production by subcutaneous adipose tissue is linked to weight loss in gastrointestinal cancer patients Br. J. Cancer 104 2011 441 447
116. A. Oliff, D. Defeo-Jones, M. Boyer, D. Martinez, D. Kiefer, G. Vuocolo, A. Wolfe, and S.H. Socher Tumors secreting human TNF/cachectin induce cachexia in mice Cell 50 1987 555 563
117. G. Pallafacchina, E. Calabria, A.L. Serrano, J.M. Kalhovde, and S. Schiaffino A protein kinase B-dependent and rapamycin-sensitive pathway controls skeletal muscle growth but not fiber type specification Proc. Natl. Acad. Sci. USA 99 2002 9213 9218 (Pubitemid 34764593)
118. M.R. Palomares, J.W. Sayre, K.C. Shekar, L.M. Lillington, and R.T. Chlebowski Gender influence on weight-loss pattern and survival of nonsmall cell lung carcinoma patients Cancer 78 1996 2119 2126 (Pubitemid 26367604)
119. L.E. Parton, C.P. Ye, R. Coppari, P.J. Enriori, B. Choi, C.Y. Zhang, C. Xu, C.R. Vianna, N. Balthasar, and C.E. Lee Glucose sensing by POMC neurons regulates glucose homeostasis and is impaired in obesity Nature 449 2007 228 232 (Pubitemid 47402365)
120. T. Preston, C. Slater, D.C. McMillan, J.S. Falconer, A. Shenkin, and K.C. Fearon Fibrinogen synthesis is elevated in fasting cancer patients with an acute phase response J. Nutr. 128 1998 1355 1360 (Pubitemid 28361429)
121. S.A. Reed, P.B. Sandesara, S.M. Senf, and A.R. Judge Inhibition of FoxO transcriptional activity prevents muscle fiber atrophy during cachexia and induces hypertrophy FASEB J. 26 2012 987 1000
122. P.J. Reeds, C.R. Fjeld, and F. Jahoor Do the differences between the amino acid compositions of acute-phase and muscle proteins have a bearing on nitrogen loss in traumatic states? J. Nutr. 124 1994 906 910 (Pubitemid 24200598)
123. D.E. Rivadeneira, H.A. Naama, M.D. McCarter, J. Fujita, D. Evoy, P. Mackrell, and J.M. Daly Glucocorticoid blockade does not abrogate tumor-induced cachexia Nutr. Cancer 35 1999 202 206 (Pubitemid 30115133)
124. F. Robert, J.R. Mills, A. Agenor, D. Wang, S. DiMarco, R. Cencic, M.L. Tremblay, I.E. Gallouzi, S. Hekimi, S.S. Wing, and J. Pelletier Targeting protein synthesis in a Myc/mTOR-driven model of anorexia-cachexia syndrome delays its onset and prolongs survival Cancer Res. 72 2012 747 756
125. C. Rommel, S.C. Bodine, B.A. Clarke, R. Rossman, L. Nunez, T.N. Stitt, G.D. Yancopoulos, and D.J. Glass Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways Nat. Cell Biol. 3 2001 1009 1013 (Pubitemid 34428746)
126. H. Ruan, N. Hacohen, T.R. Golub, L. Van Parijs, and H.F. Lodish Tumor necrosis factor-alpha suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes: nuclear factor-kappaB activation by TNF-alpha is obligatory Diabetes 51 2002 1319 1336 (Pubitemid 34826596)
127. S.T. Russell, P.M. Siren, M.J. Siren, and M.J. Tisdale The role of zinc in the anti-tumour and anti-cachectic activity of D-myo-inositol 1,2,6-triphosphate Br. J. Cancer 102 2010 833 836
128. M. Rydén, and P. Arner Fat loss in cachexia - is there a role for adipocyte lipolysis? Clin. Nutr. 26 2007 1 6 (Pubitemid 46179125)
129. M. Rydén, T. Agustsson, J. Laurencikiene, T. Britton, E. Sjölin, B. Isaksson, J. Permert, and P. Arner Lipolysis - not inflammation, cell death, or lipogenesis - is involved in adipose tissue loss in cancer cachexia Cancer 113 2008 1695 1704
130. V.T. Samuel, K.F. Petersen, and G.I. Shulman Lipid-induced insulin resistance: unravelling the mechanism Lancet 375 2010 2267 2277
131. S.E. Samuels, A.L. Knowles, T. Tilignac, E. Debiton, J.C. Madelmont, and D. Attaix Higher skeletal muscle protein synthesis and lower breakdown after chemotherapy in cachectic mice Am. J. Physiol. Regul. Integr. Comp. Physiol. 281 2001 R133 R139
132. M. Sandri, C. Sandri, A. Gilbert, C. Skurk, E. Calabria, A. Picard, K. Walsh, S. Schiaffino, S.H. Lecker, and A.L. Goldberg Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy Cell 117 2004 399 412 (Pubitemid 38534545)
133. M. Sandri, J. Lin, C. Handschin, W. Yang, Z.P. Arany, S.H. Lecker, A.L. Goldberg, and B.M. Spiegelman PGC-1alpha protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription Proc. Natl. Acad. Sci. USA 103 2006 16260 16265 (Pubitemid 44715184)
134. R. Sartori, G. Milan, M. Patron, C. Mammucari, B. Blaauw, R. Abraham, and M. Sandri Smad2 and 3 transcription factors control muscle mass in adulthood Am. J. Physiol. Cell Physiol. 296 2009 C1248 C1257
135. M. Schuelke, K.R. Wagner, L.E. Stolz, C. Hübner, T. Riebel, W. Kömen, T. Braun, J.F. Tobin, and S.J. Lee Myostatin mutation associated with gross muscle hypertrophy in a child N. Engl. J. Med. 350 2004 2682 2688 (Pubitemid 38788003)
136. H.R. Scott, D.C. McMillan, A. Crilly, C.S. McArdle, and R. Milroy The relationship between weight loss and interleukin 6 in non-small-cell lung cancer Br. J. Cancer 73 1996 1560 1562 (Pubitemid 26235384)
137. J. Shi, L. Luo, J. Eash, C. Ibebunjo, and D.J. Glass The SCF-Fbxo40 complex induces IRS1 ubiquitination in skeletal muscle, limiting IGF1 signaling Dev. Cell 21 2011 835 847
138. M. Shibata, T. Nezu, M. Takekawa, H. Takizawa, K. Ando, H. Miyake, S. Amano, and Y. Kurosu Serum levels of interleukin-10 and interleukin-12 in patients with colorectal cancer Ann. N Y Acad. Sci. 795 1996 410 412 (Pubitemid 27029606)
139. M.A. Singh, W. Ding, T.J. Manfredi, G.S. Solares, E.F. O'Neill, K.M. Clements, N.D. Ryan, J.J. Kehayias, R.A. Fielding, and W.J. Evans Insulin-like growth factor I in skeletal muscle after weight-lifting exercise in frail elders Am. J. Physiol. 277 1999 E135 E143
140. B.J. Sishi, and A.M. Engelbrecht Tumor necrosis factor alpha (TNF-α) inactivates the PI3-kinase/PKB pathway and induces atrophy and apoptosis in L6 myotubes Cytokine 54 2011 173 184
141. R.J. Skipworth, A.G. Moses, K. Sangster, C.M. Sturgeon, A.C. Voss, M.T. Fallon, R.A. Anderson, J.A. Ross, and K.C. Fearon Interaction of gonadal status with systemic inflammation and opioid use in determining nutritional status and prognosis in advanced pancreatic cancer Support. Care Cancer 19 2011 391 401
142. J. Smiechowska, A. Utech, G. Taffet, T. Hayes, M. Marcelli, and J.M. Garcia Adipokines in patients with cancer anorexia and cachexia J. Investig. Med. 58 2010 554 559
143. K.L. Smith, and M.J. Tisdale Increased protein degradation and decreased protein synthesis in skeletal muscle during cancer cachexia Br. J. Cancer 67 1993 680 685 (Pubitemid 23101543)
144. I.J. Smith, Z. Aversa, P.-O. Hasselgren, F. Pacelli, F. Rosa, G.B. Doglietto, and M. Bossola Calpain activity is increased in skeletal muscle from gastric cancer patients with no or minimal weight loss Muscle Nerve 43 2011 410 414
145. A.J. Staal-van den Brekel, A.M.W.J. Schols, G.P.M. ten Velde, W.A. Buurman, and E.F. Wouters Analysis of the energy balance in lung cancer patients Cancer Res. 54 1994 6430 6433
146. N.A. Stephens, R.J.E. Skipworth, A.J. Macdonald, C.A. Greig, J.A. Ross, and K.C.H. Fearon Intramyocellular lipid droplets increase with progression of cachexia in cancer patients J Cachexia Sarcopenia Muscle 2 2011 111 117
147. T.N. Stitt, D. Drujan, B.A. Clarke, F. Panaro, Y. Timofeyva, W.O. Kline, M. Gonzalez, G.D. Yancopoulos, and D.J. Glass The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors Mol. Cell 14 2004 395 403 (Pubitemid 38591410)
148. G. Strassmann, M. Fong, J.S. Kenney, and C.O. Jacob Evidence for the involvement of interleukin 6 in experimental cancer cachexia J. Clin. Invest. 89 1992 1681 1684
149. G. Strassmann, M. Fong, C.E. Freter, S. Windsor, F. D'Alessandro, and R.P. Nordan Suramin interferes with interleukin-6 receptor binding in vitro and inhibits colon-26-mediated experimental cancer cachexia in vivo J. Clin. Invest. 92 1993 2152 2159 (Pubitemid 23333518)
150. F. Sun, Y. Sun, Z. Yu, D. Zhang, J. Zhang, B. Song, and H. Zheng Interleukin-10 gene polymorphisms influence susceptibility to cachexia in patients with low-third gastric cancer in a Chinese population Mol. Diagn. Ther. 14 2010 95 100
151. N. Suzuki, N. Motohashi, A. Uezumi, S. Fukada, T. Yoshimura, Y. Itoyama, M. Aoki, Y. Miyagoe-Suzuki, and S. Takeda NO production results in suspension-induced muscle atrophy through dislocation of neuronal NOS J. Clin. Invest. 117 2007 2468 2476 (Pubitemid 47494348)
152. B.H.L. Tan, and K.C.H. Fearon Cytokine gene polymorphisms and susceptibility to cachexia Curr. Opin. Support. Palliat. Care 4 2010 243 248
153. B.H. Tan, L.A. Birdsell, L. Martin, V.E. Baracos, and K.C. Fearon Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer Clin. Cancer Res. 15 2009 6973 6979
154. B.H.L. Tan, T. Fladvad, T.P. Braun, A. Vigano, F. Strasser, D.A.C. Deans, R.J.E. Skipworth, T.S. Solheim, S. Damaraju, J.A. Ross European Palliative Care Research Collaborative P-selectin genotype is associated with the development of cancer cachexia EMBO Mol Med 4 2012 462 471
155. D.D. Taylor, C. Gercel-Taylor, L.G. Jenis, and D.F. Devereux Identification of a human tumor-derived lipolysis-promoting factor Cancer Res. 52 1992 829 834
156. S. Temparis, M. Asensi, D. Taillandier, E. Aurousseau, D. Larbaud, A. Obled, D. Béchet, M. Ferrara, J.M. Estrela, and D. Attaix Increased ATP-ubiquitin-dependent proteolysis in skeletal muscles of tumor-bearing rats Cancer Res. 54 1994 5568 5573 (Pubitemid 24346248)
157. S.A. Thair, K.R. Walley, T.A. Nakada, M.K. McConechy, J.H. Boyd, H. Wellman, and J.A. Russell A single nucleotide polymorphism in NF-κB inducing kinase is associated with mortality in septic shock J. Immunol. 186 2011 2321 2328
158. A. Theologides Cancer cachexia Cancer 43 5, Suppl 1979 2004 2012 (Pubitemid 9200535)
159. P.T. Todorov, W.N. Field, and M.J. Tisdale Role of a proteolysis-inducing factor (PIF) in cachexia induced by a human melanoma (G361) Br. J. Cancer 80 1999 1734 1737 (Pubitemid 29389625)
160. A.U. Trendelenburg, A. Meyer, D. Rohner, J. Boyle, S. Hatakeyama, and D.J. Glass Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size Am. J. Physiol. Cell Physiol. 296 2009 C1258 C1270
161. A.U. Trendelenburg, A. Meyer, C. Jacobi, J.N. Feige, and D.J. Glass TAK-1/p38/nNFκB signaling inhibits myoblast differentiation by increasing levels of Activin A Skelet Muscle 2 2012 3
162. W.D. van Marken Lichtenbelt, J.W. Vanhommerig, N.M. Smulders, J.M. Drossaerts, G.J. Kemerink, N.D. Bouvy, P. Schrauwen, and G.J. Teule Cold-activated brown adipose tissue in healthy men N. Engl. J. Med. 360 2009 1500 1508
163. K.A. Virtanen, M.E. Lidell, J. Orava, M. Heglind, R. Westergren, T. Niemi, M. Taittonen, J. Laine, N.J. Savisto, S. Enerbäck, and P. Nuutila Functional brown adipose tissue in healthy adults N. Engl. J. Med. 360 2009 1518 1525
164. J. Wang, J. Zhou, and C.A. Bondy Igf1 promotes longitudinal bone growth by insulin-like actions augmenting chondrocyte hypertrophy FASEB J. 13 1999 1985 1990 (Pubitemid 29517628)
165. S. Welle, K. Bhatt, C.A. Pinkert, R. Tawil, and C.A. Thornton Muscle growth after postdevelopmental myostatin gene knockout Am. J. Physiol. Endocrinol. Metab. 292 2007 E985 E991
166. J.P. White, J.W. Baynes, S.L. Welle, M.C. Kostek, L.E. Matesic, S. Sato, and J.A. Carson The regulation of skeletal muscle protein turnover during the progression of cancer cachexia in the Apc(Min/+) mouse PLoS ONE 6 2011 e24650
167. L.A. Whittemore, K. Song, X. Li, J. Aghajanian, M. Davies, S. Girgenrath, J.J. Hill, M. Jalenak, P. Kelley, and A. Knight Inhibition of myostatin in adult mice increases skeletal muscle mass and strength Biochem. Biophys. Res. Commun. 300 2003 965 971 (Pubitemid 36262030)
168. B.M. Wieland, G.D. Stewart, R.J. Skipworth, K. Sangster, K.C. Fearon, J.A. Ross, T.J. Reiman, J. Easaw, M. Mourtzakis, and V. Kumar Is there a human homologue to the murine proteolysis-inducing factor? Clin. Cancer Res. 13 2007 4984 4992 (Pubitemid 47502062)
169. S.J. Wigmore, K.C. Fearon, J.P. Maingay, and J.A. Ross Down-regulation of the acute-phase response in patients with pancreatic cancer cachexia receiving oral eicosapentaenoic acid is mediated via suppression of interleukin-6 Clin. Sci. 92 1997 215 221 (Pubitemid 27075725)
170. S.J. Wigmore, C.E. Plester, J.A. Ross, and K.C. Fearon Contribution of anorexia and hypermetabolism to weight loss in anicteric patients with pancreatic cancer Br. J. Surg. 84 1997 196 197 (Pubitemid 27073460)
171. S.J. Wigmore, P.T. Todorov, M.D. Barber, J.A. Ross, M.J. Tisdale, and K.C. Fearon Characteristics of patients with pancreatic cancer expressing a novel cancer cachectic factor Br J Surg. 87 2000 53 58 (Pubitemid 30042855)
172. A. Williams, X. Sun, J.E. Fischer, and P.-O. Hasselgren The expression of genes in the ubiquitin-proteasome proteolytic pathway is increased in skeletal muscle from patients with cancer Surgery 126 1999 744 749 discussion 749-750
173. J. Ye, Y. Zhang, J. Xu, Q. Zhang, and D. Zhu FBXO40, a gene encoding a novel muscle-specific F-box protein, is upregulated in denervation-related muscle atrophy Gene 404 2007 53 60 (Pubitemid 47562643)
174. T. Yoshikawa, Y. Noguchi, and S. Satoh Inhibition of IRS-1 phosphorylation and the alterations of GLUT4 in isolated adipocytes from cachectic tumor-bearing rats Biochem. Biophys. Res. Commun. 256 1999 676 681 (Pubitemid 29301166)
175. T. Yoshikawa, Y. Noguchi, C. Doi, T. Makino, and K. Nomura Insulin resistance in patients with cancer: relationships with tumor site, tumor stage, body-weight loss, acute-phase response, and energy expenditure Nutrition 17 2001 590 593 (Pubitemid 32633790)
176. R. Zechner, R. Zimmermann, T.O. Eichmann, S.D. Kohlwein, G. Haemmerle, A. Lass, and F. Madeo FAT SIGNALS - lipases and lipolysis in lipid metabolism and signaling Cell Metab. 15 2012 279 291
177. G. Zhang, B. Jin, and Y.P. Li C/EBPβ mediates tumour-induced ubiquitin ligase atrogin1/MAFbx upregulation and muscle wasting EMBO J. 30 2011 4323 4335
178. J. Zhao, J.J. Brault, A. Schild, P. Cao, M. Sandri, S. Schiaffino, S.H. Lecker, and A.L. Goldberg FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells Cell Metab. 6 2007 472 483 (Pubitemid 350163056)
179. X. Zhou, J.L. Wang, J. Lu, Y. Song, K.S. Kwak, Q. Jiao, R. Rosenfeld, Q. Chen, T. Boone, and W.S. Simonet Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival Cell 142 2010 531 543
180. R. Zimmermann, J.G. Strauss, G. Haemmerle, G. Schoiswohl, R. Birner-Gruenberger, M. Riederer, A. Lass, G. Neuberger, F. Eisenhaber, A. Hermetter, and R. Zechner Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase Science 306 2004 1383 1386 (Pubitemid 39532517)
181. T.A. Zimmers, M.V. Davies, L.G. Koniaris, P. Haynes, A.F. Esquela, K.N. Tomkinson, A.C. McPherron, N.M. Wolfman, and S.J. Lee Induction of cachexia in mice by systemically administered myostatin Science 296 2002 1486 1488 (Pubitemid 34553097)
182. S.D. Zuijdgeest-van Leeuwen, J.W. van den Berg, J.L. Wattimena, A. van der Gaast, G.R. Swart, J.H. Wilson, and P.C. Dagnelie Lipolysis and lipid oxidation in weight-losing cancer patients and healthy subjects Metabolism 49 2000 931 936 (Pubitemid 30483448)
183. Z. Zylicz, O. Schwantje, D.J. Wagener, and H.T. Folgering Metabolic response to enteral food in different phases of cancer cachexia in rats Oncology 47 1990 87 91 (Pubitemid 20027746)